Put Options

23 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $38,850 - $76,368
22,200 Added 142.31%
37,800 $124,000
Q4 2023

Feb 14, 2024

SELL
$1.74 - $2.31 $696 - $924
-400 Reduced 2.5%
15,600 $32,000
Q3 2023

Nov 15, 2023

SELL
$2.11 - $3.28 $21,311 - $33,128
-10,100 Reduced 38.7%
16,000 $33,000
Q2 2023

Aug 23, 2023

SELL
$1.97 - $3.69 $9,062 - $16,974
-4,600 Reduced 14.98%
26,100 $83,000
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $65,698 - $104,380
30,700 New
30,700 $66,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $87,341 - $153,762
52,300 New
52,300 $121,000
Q4 2021

Feb 14, 2022

SELL
$1.22 - $1.72 $1,098 - $1,548
-900 Reduced 3.54%
24,500 $31,000
Q3 2021

Nov 12, 2021

SELL
$1.2 - $1.5 $15,120 - $18,900
-12,600 Reduced 33.16%
25,400 $35,000
Q2 2021

Aug 06, 2021

BUY
$1.25 - $1.83 $10,500 - $15,372
8,400 Added 28.38%
38,000 $53,000
Q1 2021

May 14, 2021

SELL
$1.52 - $2.1 $17,936 - $24,780
-11,800 Reduced 28.5%
29,600 $45,000
Q4 2020

Feb 12, 2021

BUY
$1.55 - $2.05 $2,790 - $3,689
1,800 Added 4.55%
41,400 $66,000
Q3 2020

Nov 13, 2020

SELL
$1.59 - $2.19 $5,724 - $7,884
-3,600 Reduced 8.33%
39,600 $70,000
Q2 2020

Aug 13, 2020

BUY
$1.05 - $2.18 $3,990 - $8,284
3,800 Added 9.64%
43,200 $91,000
Q1 2020

May 11, 2020

SELL
$0.89 - $1.49 $9,790 - $16,390
-11,000 Reduced 21.83%
39,400 $45,000
Q4 2019

Feb 12, 2020

SELL
$1.27 - $1.54 $1,778 - $2,156
-1,400 Reduced 2.7%
50,400 $68,000
Q3 2019

Nov 14, 2019

BUY
$1.15 - $1.59 $4,945 - $6,837
4,300 Added 9.05%
51,800 $70,000
Q2 2019

Aug 20, 2019

SELL
$1.37 - $2.02 $27,537 - $40,602
-20,100 Reduced 29.73%
47,500 $67,000
Q1 2019

May 15, 2019

SELL
$1.01 - $1.83 $21,715 - $39,345
-21,500 Reduced 24.13%
67,600 $112,000
Q4 2018

Feb 14, 2019

SELL
$0.98 - $1.85 $264,012 - $498,390
-269,400 Reduced 75.15%
89,100 $91,000
Q3 2018

Nov 14, 2018

BUY
$1.76 - $6.38 $512,160 - $1.86 Million
291,000 Added 431.11%
358,500 $631,000
Q1 2018

May 15, 2018

BUY
$1.81 - $5.98 $93,758 - $309,764
51,800 Added 329.94%
67,500 $287,000
Q4 2017

Feb 14, 2018

SELL
$1.8 - $2.32 $64,080 - $82,592
-35,600 Reduced 69.4%
15,700 $28,000
Q3 2017

Nov 15, 2017

BUY
$1.99 - $2.65 $102,087 - $135,945
51,300
51,300 $112,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.59B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.